Medicine
Showing 1-10 of 69 Results
-
Sally Arai
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Current Research and Scholarly InterestsResearch interest in utilizing post-transplant adoptive cellular immunotherapy to reduce GVHD and relapse in patients with high risk hematologic malignancies.
-
Cameron Scott Bader
Postdoctoral Scholar, Bone Marrow Transplantation
BioMy research is focused on using preclinical models to develop novel therapies which improve outcomes for patients receiving allogeneic hematopoietic stem cell transplantation. Currently, my work aims to establish strategies to reduce the risk of relapse after allogeneic hematopoietic stem cell transplantation without exacerbating graft-versus-host disease or interfering with donor stem cell engraftment.
-
Sushma Bharadwaj, MD
Clinical Assistant Professor, Medicine - Blood & Marrow Transplantation
BioDr. Bharadwaj is fellowship-trained in blood and marrow transplantation, cellular therapy, hematology, and oncology. She is an instructor in the Stanford School of Medicine Department of Medicine, Division of Blood & Marrow Transplantation and Cellular Therapy.
Dr. Bharadwaj focuses her expertise on diagnosing and treating cancer in blood and bone marrow. For each patient, she develops a personalized, comprehensive, and compassionate care plan. In her diverse experience as a physician and scientist, she has served as an internal medicine doctor, hospitalist, hematologist, oncologist, and blood and marrow transplantation specialist. Dr. Bharadwaj has a degree in clinical research and is currently conducting clinical trials in transplant and cellular therapy.
She has participated in research studies of advances in therapy for chronic lymphocytic leukemia, melanoma, and breast cancer. She has co-authored articles published in Leukemia and Lymphoma and elsewhere. Topics include advances in cell transplantation. She also co-wrote the chapter on genome-driven personalized cancer therapy in the book Precision Medicine in Oncology.
Dr. Bharadwaj has made presentations at meetings of the American Society of Hematology, American Society of Clinical Oncology, and other associations.
Subjects include racial, demographic, and socioeconomic disparities in the treatment of patients with acute myeloid leukemia.
Dr. Bharadwaj is a member of the American Society for Transplantation and Cellular Therapy, American Society of Hematology, and American Society of Clinical Oncology. -
Saurabh Dahiya, MD, FACP
Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
BioDr. Saurabh Dahiya is a cancer specialist board-certified in internal medicine, hematology, and medical oncology. He serves as Associate Professor of Medicine at Stanford University School of Medicine and Clinical Director of Cell Therapy in the Division of Blood and Marrow Transplantation and Cell Therapy, where he provides patient-centered care for individuals with cancer.
Dr. Dahiya’s research focuses on advancing cellular immunotherapies for hematologic malignancies, including CAR T-cell platforms and next-generation multiantigen targeting strategies for lymphoma. His work aims to address high tumor bulk disease and develop novel cell therapy approaches that enhance durability and response in hematologic cancers. He leads multiple investigator-initiated and industry-sponsored trials in cellular immunotherapy with a focus on translating correlative research insights into improved patient outcomes.
He has authored more than 100 peer-reviewed publications in journals such as The New England Journal of Medicine, Nature Medicine, Journal of Clinical Oncology, Blood, and Blood Advances. Dr. Dahiya serves as Hematology Lead Editor for Critical Reviews in Oncology and Hematology and is an active member of ASH, ASTCT, and ASCO. Before joining Stanford, he was on faculty at the University of Maryland’s Greenebaum Comprehensive Cancer Center, where he helped develop the Cellular Immunotherapy Program.
